[1] |
WATCHKO JF, TIRIBELLI C. Bilirubin-induced neurologic damage-mechanisms and management approaches[J]. N Engl J Med, 2013, 369(21): 2021-2030. DOI: 10.1056/NEJMra1308124.
|
[2] |
DHAWAN A, LAWLOR MW, MAZARIEGOS GV, et al. Disease burden of Crigler-Najjar syndrome: Systematic review and future perspectives[J]. J Gastroenterol Hepatol, 2020, 35(4): 530-543. DOI: 10.1111/jgh.14853.
|
[3] |
MARUO Y, NAKAHARA S, YANAGI T, et al. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type Ⅱ and Gilbert syndrome[J]. J Gastroenterol Hepatol, 2016, 31(2): 403-408. DOI: 10.1111/jgh.13071.
|
[4] |
BIANCO A, DVO RŘÁK A, CAPKOVÁ N, et al. The extent of intracellular accumulation of bilirubin determines its anti- or pro-oxidant effect[J]. Int J Mol Sci, 2020, 21(21): 8101. DOI: 10.3390/ijms21218101.
|
[5] |
VÍTEK L. The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases[J]. Front Pharmacol, 2012, 3: 55. DOI: 10.3389/fphar.2012.00055.
|
[6] |
LAPENNA D, CIOFANI G, PIERDOMENICO SD, et al. Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis[J]. Clin Exp Med, 2018, 18(1): 119-124. DOI: 10.1007/s10238-017-0470-5.
|
[7] |
ZULUS B, GRVNBACHER G, KLEBER ME, et al. The UGT1A1*28 gene variant predicts long-term mortality in patients undergoing coronary angiography[J]. Clin Chem Lab Med, 2018, 56(4): 560-564. DOI: 10.1515/cclm-2017-0692.
|
[8] |
AONO S, YAMADA Y, KEINO H, et al. Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type Ⅱ[J]. Biochem Biophys Res Commun, 1993, 197(3): 1239-1244. DOI: 10.1006/bbrc.1993.2610.
|
[9] |
ARIAS IM, LONDON IM. Bilirubin glucuronide formation in vitro; demonstration of a defect in Gilbert's disease[J]. Science, 1957, 126(3273): 563-564. DOI: 10.1126/science.126.3273.563.
|
[10] |
BOSMA PJ, CHOWDHURY JR, BAKKER C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucurono-syltransferase 1 in Gilbert's syndrome[J]. N Engl J Med, 1995, 333(18): 1171-1175. DOI: 10.1056/NEJM199511023331802.
|
[11] |
VITEK L, BELLAROSA C, TIRIBELLI C. Induction of mild hyperbilirubinemia: Hype or real therapeutic opportunity?[J]. Clin Pharmacol Ther, 2019, 106(3): 568-575. DOI: 10.1002/cpt.1341.
|